Literature DB >> 19478455

Crystallization and preliminary crystallographic studies of human RIG-I in complex with double-stranded RNA.

Hyunjin Moon1, Jungwoo Choe.   

Abstract

Retinoic acid inducible gene-I (RIG-I) is an essential component of the innate immune system that is responsible for the detection and elimination of invading viruses. RIG-I recognizes viral RNAs inside the cell and then initiates downstream signalling to activate the IRF-3 and NF-kappaB genes, which results in the production of type I interferons. RIG-I is composed of an N-terminal CARD domain for signalling and C-terminal helicase and repressor domains for RNA recognition. A RIG-I-RNA binding assay was performed to investigate the in vitro RIG-I-RNA binding properties. Selenomethionine-incorporated RIG-I was expressed using Escherichia coli and purified for crystallization. X-ray data were collected from RIG-I-dsRNA complex crystals to 2.8 A resolution using synchrotron radiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478455      PMCID: PMC2688434          DOI: 10.1107/S1744309109018405

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  20 in total

1.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

Review 3.  [RIG-I: critical regulator for virus-induced innate immunity].

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  Tanpakushitsu Kakusan Koso       Date:  2004-12

4.  RIG-I: an essential regulator of virus-induced interferon production.

Authors:  M H Heim
Journal:  J Hepatol       Date:  2005-03       Impact factor: 25.083

Review 5.  Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses.

Authors:  Etienne Meylan; Jürg Tschopp
Journal:  Mol Cell       Date:  2006-06-09       Impact factor: 17.970

6.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

7.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.

Authors:  Taro Kawai; Ken Takahashi; Shintaro Sato; Cevayir Coban; Himanshu Kumar; Hiroki Kato; Ken J Ishii; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

8.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

9.  Subcellular localization of Toll-like receptor 3 in human dendritic cells.

Authors:  Misako Matsumoto; Kenji Funami; Masako Tanabe; Hiroyuki Oshiumi; Masashi Shingai; Yoshiyuki Seto; Akitsugu Yamamoto; Tsukasa Seya
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

10.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

View more
  1 in total

1.  Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction.

Authors:  Kay Childs; Richard Randall; Stephen Goodbourn
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.